Publication
Depression and anxiety symptoms following cancer diagnosis: a cross-sectional study.
dc.contributor.author | Cardoso, G | |
dc.contributor.author | Graça, J | |
dc.contributor.author | Klut, C | |
dc.contributor.author | Trancas, B | |
dc.contributor.author | Papoila, A | |
dc.date.accessioned | 2017-01-10T15:20:47Z | |
dc.date.available | 2017-01-10T15:20:47Z | |
dc.date.issued | 2016 | |
dc.description.abstract | INTRODUCTION: The aims of the present study were to assess demographic and clinical characteristics of patients after receiving a cancer diagnosis, and to determine possible risk factors for anxiety and depression. METHODS: All consecutive patients aged 18 or above, were assessed before starting intravenous chemotherapy for the first time with the Hospital Anxiety and Depression Scale (HADS), the Distress Thermometer, and a Visual Analog Scale for pain. Demographic and clinical data were also collected. RESULTS: The patients assessed (n = 270) had a mean age of 59.4 (SD = 11.8) years, and 50.7% were women. Tumours were more frequently colorectal (27.2%), lung (18.8%) and breast (17.6%), and 68.9% were stages 3 or 4. A HADS Anxiety score ≥8 was present in 30% of the patients, a Depression score ≥8 in 24.1%, and a Distress score ≥4 in 44.4%. Independent risk factors for HADS Depression score ≥8 were being a woman (OR = 2.45; p = 0.004), being older (OR = 1.04; p = 0.005), and cancer stage 3-4 (OR = 2.24; p = 0.023) in the multivariable analysis; for Anxiety ≥8 they were being a woman (OR = 2.47; p = 0.002), having a past psychiatric consultation (OR = 2.83; p = 0.029), and cancer stage 3-4 (OR = 1.90; p = 0.047). CONCLUSION: These results suggest the need for greater awareness and a differentiated approach to patients at increased risk of anxiety and depression in the early stages of treatment and before starting chemotherapy. | pt_PT |
dc.description.version | info:eu-repo/semantics/publishedVersion | pt_PT |
dc.identifier.citation | Psychol Health Med. 2016 Jul;21(5):562-70 | pt_PT |
dc.identifier.doi | 10.1080/13548506.2015.1125006 | pt_PT |
dc.identifier.issn | 1465-3966 | |
dc.identifier.uri | http://hdl.handle.net/10400.10/1787 | |
dc.language.iso | eng | pt_PT |
dc.peerreviewed | yes | pt_PT |
dc.publisher | Taylor & Francis | pt_PT |
dc.subject | Depression | pt_PT |
dc.subject | Anxiety | pt_PT |
dc.subject | Neoplasms | pt_PT |
dc.title | Depression and anxiety symptoms following cancer diagnosis: a cross-sectional study. | pt_PT |
dc.type | journal article | |
dspace.entity.type | Publication | |
oaire.citation.conferencePlace | Abingdon | pt_PT |
oaire.citation.endPage | 570 | pt_PT |
oaire.citation.startPage | 562 | pt_PT |
oaire.citation.title | Psychology, health, and medicine | pt_PT |
oaire.citation.volume | 21 | pt_PT |
rcaap.rights | restrictedAccess | pt_PT |
rcaap.type | article | pt_PT |